Hydrocodone

Among the most frequently prescribed analgesics in the United States for moderate to severe pain, hydrocodone is a semisynthetic opioid and Schedule II controlled substance. Routine laboratory monitoring of hydrocodone is performed in pain management compliance programs to assess patient adherence, detect potential diversion, and evaluate expected metabolites including hydromorphone and norhydrocodone. UTAK’s comprehensive pain management and drugs of abuse panels contain hydrocodone in urine and whole blood matrices at multiple concentration levels, supporting both immunoassay screening and LC-MS/MS confirmatory methods used in clinical and forensic laboratories. Stock and custom QC solutions can incorporate the primary metabolite hydromorphone along with related opioids such as oxycodone, morphine, codeine, fentanyl, methadone, buprenorphine, tramadol, and other commonly monitored analytes to support comprehensive pain management and controlled substance QC programs.